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by Vernon E. Steele,* Douglas C. Toppingt and
S. Balakrishna Pai*
The tracheal epithelium of the Fischer 344 rat is histologically very similar to that of the human
bronchus. Also, carcinomas of tracheal origin in F-344 rats are similar in morphology to human
bronchogenic carcinomas. Tumor promotion in rat tracheal epithelium was studied by using two mo-
del systems.
The first is a heterotopic transplant system in which rat tracheas are implanted subcutaneously
on the backs of isogenic recipents. In the first system, the epithelium was topically exposed to pel-
lets containing 7,12-dimethylbenz(a)anthracene (DMBA), used as the initiating agent, followed by
pellets containing the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), the promoting
agent. After 98 weeks, a three- to fourfold increase in the percentage of tracheas having malignant
tumors was seen in tracheal transplants receiving both DMBA and TPA compared to DMBA alone.
Exposure of the tracheal grafts to TPA alone resulted in epithelial hyperplasia and inflammation,
but no dysplastic lesions.
The second system is an organ culture-cell culture system in which small pieces of trachea are
grown in organ culture, then epithelial cells are grown from these pieces as primary cell cultures.
The organ cultures were exposed to the direct alkylating agent, N-methyl-N'-nitro-N -nitrosoguani-
dine (MNNG) used as the initiator, then multiple short exposures to TPA were used to promote. Pri-
mary cell cultures and cell lines were then established from these explants. After 52 weeks, a five-
fold increase in the percentage of explants producing tumorigenic cell lines was observed when
MNNG + TPA-exposed explants were compared to MNNG-exposed explants. Tracheal explants ex-
posed to TPA alone produced many cell lines but none tested were tumorigenic. These two systems
provide a means to study tumor promotion in respiratory epithelium. The evidence more impor-
tantly suggests that airborne promoting substances may play a key role in the development of bron-
chogenic carcinoma.
Introduction
The epithelial mucosa lining the human respira-
tory tract is in contact with a wide variety of envi-
ronmental pollutants. These pollutants are chiefly
made up of particulates and/or gases. Epidemiologi-
cal evidence suggests with some degree of certainty
that lung cancer in humans is a multistage process
(1-3). It is extremely difficult to separate and under-
stand the interacting, synergistic and promoting ef-
fects of toxic agents in humans since man is continu-
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ously exposed to complex mixtures such as ciga-
rette smoke and automobile exhaust. To delineate
these processes and understand them, animal and
cell culture models using respiratory tract epithe-
lium have been developed. To develop these sys-
tems for the study of tumor promotion in the respi-
ratory tract, certain assumptions and simplifications
have been made. Rat tracheal epithelium was
chosen because it is histologically similar to human
bronchial epithelium; the tumors arising from this
tissue are similar in morphology to human broncho-
genic carcinomas; and there is an extremely low
background incidence of spontaneous respiratory
tract tumors in specific pathogen-free F-344 rats.
For simplification, single initiators and single pro-
moters were used. The initiators employed here are
known carcinogens, either direct acting or requiring
metabolic activation. The promoter used was the
phorbol diester tumor promoter proven most activeSTEELE, TOPPING AND PAI
in mouse skin, 12-O-tetradecanoyl-phorbol-13-acetate
or TPA (4).
To demonstrate the phenomenon of tumor promo-
tion in tracheal epithelium, the heterotopic tracheal
transplant system was utilized (5). The qualitative
and quantitative aspects of the tumor response
have been previously established for the transplant
system (6). Other studies have developed methodol-
ogy for the controlled release and accurate dosing
of carcinogens and phorbol esters to the tracheal
mucosa (7). By using this system, crysotile asbestos
and nickel subsulfide have been shown to enhance
the tumor frequency of DMBA-initiated tracheal
cells (8, 9). Cell culture models using similar tissue
have also been developed. Previous studies have
shown that in vitro exposed tracheal epithelium
could be transformed in a dose- dependent manner
(10). The tumors formed following the inoculation of
transformed epithelial cell lines were similar in mor-
phology to those induced in vivo but appeared in a
much shorter time span. A preliminary set of exper-
iments also showed that the mucociliary epithelium
of cultured tracheal explants responds to phorbol
ester exposure by a dramatic increase in cell prolif-
eration (11, 12). The kinetics of DNA synthesis in
the cultured rat tracheal epithelium was very simi-
lar to that of mouse skin. The extent of stimulation
was dependent on the duration of exposure, the con-
centration of TPA, and the serum level of the me-
dium. These findings led to the design of the initia-
tion promotion experiments described here.
Materials and Methods
Tracheal Transplants
Freshly excised tracheas from female animals
were sutured onto a slightly longer length of semi-
rigid polyethylene tubing. After the tracheal grafts
had established, pellets, prepared as described
below, were surgically placed into the tracheal lu-
mena and the openings were closed with silk suture
material. Two tracheas per host were implanted
subcutaneously to the retroscapular region as de-
scribed previously (5).
Pellets for Chemical Exposure
The carcinogen initiator used was 7,12-dimethyl-
benz(a)anthracene (DMBA) which was purchased
from Eastman Kodak Co. (Rochester, NY) and re-
crystallized before use. The tumor promoting agent
was 12-O-tetradecanoylphorbol-13-acetate (TPA)
from Dr. Peter Borchert (University of Minnesota,
Minneapolis, MN). The DMBA and TPA were dis-
solved in melted beeswax and molded into cylindri-
cal pellets. The procedures for making pellets has
been described previously (5, 7). The final concentra-
tions of DMBA or TPA in the pellets were deter-
mined by ultraviolet spectrophotometry.
Experimental Design
Tracheal transplants were first either exposed to
pellets containing DMBA or blank beeswax pellets.
After 4 weeks the DMBA pellets were surgically re-
moved and pellets containing TPA or blank bees-
wax were inserted. Similarly, the beeswax pellets
were replaced with pellets containing TPA. Hence,
all transplants underwent the same number of sur-
gical manipulations and all contained pellets
throughout the experiment. The transplanted
tracheas were palpated biweekly for tumor appear-
ance. Tracheas with tumors 2 cm in diameter were
removed from the experiments. All remaining tra-
cheas were harvested after 98 weeks and histologi-
cally examined for lesions resulting from chemical
exposure.
Organ Culture
Tracheas were excised from Fischer 344 female
rats and cut into explants, 2 x 3 mm, as described
by Marchok et al. (13). The explants were placed in
organ culture dishes (Falcon Plastics, Oxnard, CA)
on Gelman TCM filter paper (Gelman Instruments
Co., Ann Arbor, MI) supported by a stainless steel
grid.
Chemical Exposures
The direct acting carcinogen, N-methyl-N'-nitro-
N-nitrosoguanidine (MNNG), from Starks Inc.
(Buffalo, NY), was used as the initiating agent.
Exposure of the organ cultures lasted for 3 hr on
days 3 and 6. The TPA was prepared as described
previously (11). Three days after the last carcinogen
exposure the explants were exposed for 1 hr to
either 0 or 1.0 lAg TPA/mL medium every 6 days for
3 weeks. The exposures were performed in serum-
free Waymouth's medium with the dimethyl-
sulfoxide solvent concentration at 0.2%. Control
cultures received 0.2% dimethyl sulfoxide alone.
Cell Culture
Following the last TPA exposure, the explants
were placed on the bottom of organ culture dishes
to stimulate the outgrowth of epithelial cells. The
explants were replanted weekly for 10 weeks to
maximize the number of epithelial cells reaching the
surface of the dish. Epithelial cell lines were estab-
lished from primary cultures after the appearance
of morphologically altered cells. The cultures and
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subcultures were passaged by using 0.2% trypsin-
EDTA (Grand Island Biological Co., Grand Island,
NY).
Assay for Tumorigenicity
Epithelial cell lines which reached the fifth pas-
sage at certain times after exposure were inocu-
lated into immunosuppressed isogenic rats as de-
scribed previously. Four inoculations of 106 cells
each were placed intramuscularly into the hind legs
of two animals at each time point. The legs were
palpated twice weekly for the appearance of tu-
mors. The appearance of one tumor from four
inoculations was considered a positive test. The ani-
mals were observed for 100 days and the tumors
were histologically examined to verify tumor type.
Primary Cell Culture Exposures
Tracheal epithelial cells were enzymatically re-
moved from male F-344 rat tracheas as described by
Wu and Smith (15). The cells were plated on colla-
gen-coated tissue culture dishes (15). Attached cells
were exposed to carcinogen in serum-free medium
beginning on day 1 for 3 hr and at various days
thereafter. All cell counts were done by hemocyto-
meter. Subculturing was performed by using 0.2%
trypsin-EDTA.
Results
Heterotopic Tracheal Transplant System
Over the 4-week period that the 200 Mg DMBA
pellets were inside the tracheal graft, an average of
188 j.g of DMBA was released per trachea. The 100
Mg TPA pellets released over 80 Mg of TPA in the
first 4 months (approximately 1.1 Mg/day for the
first 2 months and 0.3 pg/day the second 2 months).
It is assumed that nearly all 100 ,.g of TPA was de-
livered if the pellet remained in the full 94 weeks of
the experiment. Of the 20 tracheas exposed only to
188 MAg DMBA (no TPA), only three developed pal-
palpable invasive carcinomas and three more with
tained a microinvasive carcinoma (Table 1). If the
tracheas were only exposed to the TPA pellets (no
DMBA) then no tumors formed. Combining these
two agents in 22 tracheas yielded 13 tracheas with
palpable invasive carcinomas and three more with
noninvasive exophytic carcinomas growing into the
tracheal lumen. Previous studies have,,shown that
no tumors are found in tracheas receiving blank
beeswax pellets for this time period (6).
Tracheas not developing tumors were examined
histologically. In the DMBA + TPA group, all of
the remaining tracheas contained one or more meta-
Table 1. Tumor promotion in tracheas
exposed to DMBA and/or TPA
DMBA, TPA,
,mg delivered pg delivered No. of Carcinoma
per trachea per trachea tracheas incidence, %
Experiment la
188 0 20 20
0 100 20 0
188 100 22 73
Experiment 2b
35 - 26 4
35 0 38 5
35 100 56 34
aIn this experiment pellets containing 200 ,ug of DMBA or
blank beeswax were inserted for 4 weeks then 100 pg TPA
pellets were inserted for up to 98 weeks. Modified from
Topping and Nettesheim (16).
bExperiment 2 utilized 100 lAg DMBA pellets inserted for 2
weeks followed by no pellets (-), blank beeswax pellets (0) or
100 ,ug TPA pellets. From Klein-Szanto (17).
plastic-dysplastic lesion(s). Of tracheas exposed to
DMBA alone and not developing tumors, five of the
16 had lesions, while none of the tracheas in the
TPA only group had lesions.
The effect of TPA on DMBA exposed tracheas
was not only that of increasing the frequency of tu-
mors, but that the tumors appeared much earlier.
The first tumor in the DMBA + TPA group
reached 2 cm in diameter at 57 weeks while the
first tumor in the DMBA alone group took 80
weeks, nearly 6 months longer. Overall, 10 of the 13
palpable tumors in the DMBA + TPA group had
reached 2 cm in diameter and were removed before
the first tumor appeared in the DMBA only group.
In a second set of experiments by Klein-Szanto
(17), also summarized in Table 1, transplants were
exposed to pellets containing 100 Mg DMBA of
which 35 ,g was delivered during a 2-week expo-
sure period. In 38 tracheas exposed only to 35 Mg
DMBA, only 2 developed carcinomas by 86 weeks.
In contrast, if the DMBA pellets were followed by
100 ,ug TPA pellets, 19 of the 56 tracheal trans-
plants or 34% developed tumors. The first tumor in
the DMBA + TPA group reached 2 cm at approxi-
mately 43 weeks, while the first tumor in the
DMBA alone group reached equal size at 47 weeks.
Results similar to DMBA + beeswax were re-
corded if no second pellet was implanted.
Organ Culture-Cell Culture System
A schematic diagram of the organ culture-cell cul-
ture system is shown in Figure 1. Since previous
studies had shown that a concentration of 0.001 pg
MNNG/mL produced tumorigenic cell lines (10), a
10-fold lower concentration, 0.1 ng MNNG/mL, was
expected to minimize the transformation frequency.
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FIGURE 1. Diagram oforgan culture-cell culture system used for promotion studies.
Table 2. Interval between carcinogen exposure and various stages in the establishment of cell lines from
MMNG ± TPA exposed epithelium.a
Average time from carcinogen exposure
No.of ± SE, days
cell To appearance To To
MNNG, TPA, lines of morphologically first fifth
pg/mL pg/mL established altered cellsb passage" passage
O 0 0 - -
0.0001 1.0 11 132 ± 11 167 ± 26 201 ± 33
0 1.0 14 190 ± 21 213 ± 15 287 22
0.0001 0 10 209 ± 10 242 ± 14 315 ± 12
aModified from Steele et al. (18).
bAppearance ofsmall irregular-shaped, rapidly growing cells.
cPrimary cultures were dissociated for the first time when approximatly 106 morphologically altered cells had accumulated.
The TPA concentration and exposure duration
were chosen since previous studies had shown that
under these conditions there was a maximal in-
crease in cell proliferation (12). Three major events
were scored during the course of the experiment in
terms of time of occurrence after MNNG exposure
and frequency: (1) the appearance of morphologi-
cally altered cells, (2) the establishment of cell lines
and (3) the development of oncogenicity. Table 2
shows the time and frequency of the establishment
of cell lines from morphologically altered cells. As
we had observed previously (18), morphologically
altered cells appeared in primary cell cultures be-
tween 3 and 7 months following carcinogen expo-
sure. These cells had a markedly higher nuclear- to-
cytoplasmic ratio, were smaller and remained
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tightly packed as they grew rapidly across the
surface of the dish. Unexpectedly, TPA exposure
also induced the appearance of these cells and sub-
sequently we were able to subculture continuously
proliferating cell lines (11). There were no gross
morphological differences between carcinogen in-
duced or TPA induced morphologically altered cells
or cell lines. An example of one such cell line is
shown in Figure 2. Primary cell cultures not con-
taining morphologically altered cells were main-
tained for up to 7 months, but subculture of unal-
tered cells was unsuccessful. No morphologically al-
tered cells were seen in solvent control cultures. In
cultures derived from MNNG + TPA treated
explants, morphologically altered cells appeared at
about 132 days, significantly sooner (p<0.05) than in
primary cultures derived from explants exposed to
only MNNG which was 209 days. When the altered-
cell patches reached 2-3 cm in diameter, attempts
were made to subculture the cells. Future sub-
cultures were made at confluency. The time
required for the cells to grow to confluency four
times from the first subculture to the fifth sub-
culture was markedly shortened in the MNNG +
TPA group compared to the MNNG only or TPA
only group. An average of only 34 days was needed
in the MNNG + TPA group, while 73 days were
needed in the MNNG only group, and 74 days in the
TPA only group. This acceleration of growth was
accompanied by an acceleration of tumorigenic po-
tential. Of the five cell lines tested before passage
9 in the MNNG + group, three were tumorigenic.
In contrast, of the eight cell lines tested before
passage 9 in the MNNG-only group, none was
tumorigenic. In order to assess a true acceleration
of tumor formation due to TPA exposure, the cell
lines were inoculated at various times up to 1 year
after carcinogen exposure. Table 3 shows that no tu-
mors resulted from the inoculations of the 14 cell
lines derived from explants exposed to TPA alone.
Of the ten cell lines derived from explants exposed
only to MNNG only three were tumorigenic at 365
days and neither of the two cell lines that had been
established by 310 days were tumorigenic. Cell lines
derived from explants receiving MNNG + TPA
were established as early as 150 days, and six of the
eight tumorigenic cell lines were tumorigenic at 310
days and earlier.
The tumors were excised when they reached 2 to
3 cm in diameter and examined histologically. All
Table 3. Frequency of tumorigenic cell lines at various
times after exposure to MNNG and/or TPA.
Times after Frequency oftumorigenic cell lines
first MNNG (no. tumorigenic/no. inoculated)b
exposure, days TPA MNNG MNNG + TPA
100 0/0 0/0 0/0
150 0/0 0/0 1/1
200 0/0 0/0 3/3
250 0/2 0/0 3/4
310 0/6 0/2 6/7
365 0/14 3/10 8/11
aModified from Steele et al. (19).
bThe tumors were all differentiated carcinomas. The number
inoculated also represents the total number of lines which had
reached the fifth passage or more by the indicated timepoint.
FIGURE 2. Typical tracheal epithelial cell line derived from explants exposed to MNNG and/or TPA. Phase contrast, x 1.50.
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FIGURE 3. Adenosquamous cell carcinoma resulting from the inoculation of tracheal epithelial cells malignantly transformed in
vitro. H & E; x 250.
FIGURE 4. Squamous cell carcinoma resulting from
tumors were either squamous cell carcinomas or
adenosquamous cell carcinomas (Figs. 3 and 4). The
time between inoculation and tumor appearance did
not appear to be shorter for the tumorigenic cell
lines in the MNNG + TPA group compared to the
tumorigenic cell lines on the MNNG only group.
Also the growth rate of the tumors once palpable
appeared equal in the two groups.
!9G-exposed tracheal epithelial cells. H & E; x 250.
Correlation of Growth Promotion and
Tumor Promoting Activity
The ability to enhance in vitro growth seems to
be a common property of carcinogens and the tumor
promoter TPA. To determine if this phenomenon
relates to tumor promotion we asked the following
questions. Does the enhancement of growth in cul-
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tured tracheal epithelium correlate with the ability
of various compounds to promote mouse skin carci-
nogenesis? Using the organ culture-cell culture sys-
tem we exposed explants to various compounds as
shown in Table 4 and assayed their ability to induce
cell lines. Four 1-hr exposures to mezerine, a non-
promoting TPA analog, and acetic acid induced no
cell lines. A very low percentage of cell lines was
established from DMSO, phorbol, and 4-0-methyl
TPA-exposed explants. Four exposures to TPA at 1
or 0.01 Ag/mL produced a high percentage of cell
lines. A single 1-hr exposure to 1 ,.g TPA/mL was
not nearly as effective as multiple exposures.
Enhancement of Growth Using Primary
Tracheal Epithelial Cells
When 104 freshly isolated tracheal cells are plated
in a collagen-coated 60 mm dish, they grow and
reach confluency at 10-14 days, then senesce and ex-
foliate from the dish. Single or multiple MNNG ex-
posures can cause a dramatic growth alteration in
cells of similar cultures. These cells escape the sen-
escence process and become established cell lines.
Table 5 shows that increasing numbers of cells are
present at day 30 as the number of exposure to
MNNG increased. Attempts to establish cell lines
from these cultures were more successful after
multiple MNNG exposures than with a single expo-
sure. Six or eight MNNG exposures was the most
efficient.
In preliminary experiments we found that TPA
can also induce cell lines following multiple expo-
sures of primary epithelial cell cultures (data not
shown). From these data we have designed an initia-
tion-promotion scheme consisting of a single low
dose of MNNG given on day 1 of culture followed
by multiple TPA exposures between days 6 and 30.
The single low dose of MNNG (0.01 ,ug/mL) pro-
duced no cell lines in previous studies (Pai et al., un-
published data). The TPA concentrations chosen ei-
Table 4. Cell line establishment following exposure
of cultured tracheal explants to promoters/nonpromoters.
No. ofcell lines
Con- per
No. of centration, no.exposed
Chemical exposures pg/mL explants %
DMSO 4 0.2% 1/15a 7
Mezerine 4 1 0/8 0
Acetic Acid 4 0.012% 0/8 0
Phorbol 4 1 2/12 17
4-0-MeTPA 4 1 1/9 11
TPA 4 1 6/8a 75
TPA 1 1 2/8 25
TPA 4 .01 5/5 100
aCombined results of two experiments.
ther induce few or no cell lines. The objective of
these experiments is to determine if initiated cells
are more susceptible to growth alteration than non-
initiated cells, and to develop a rapid assay system
for promoting compounds of the respiratory tract.
Discussion
The in vivo and in vitro experiments described
here demonstrate that two-stage carcinogenesis in-
deed occurs in respiratory tract epithelium. Fol-
lowing the initiation of tracheal cells by a chemical
carcinogen, exposure to a known tumor promoting
substance both increases the frequency of final tu-
mor yield and decreases the latency period to tumor
appearance in animals and in cultured cells. Expo-
sure of respiratory epithelial cells to a tumor pro-
moter alone causes a reversible hyperplasia in vivo
and a permanent loss of growth control in cultured
cells. This loss of growth control in cultured cells
correlates with the promoting potential of various
agents as measured in the mouse skin model. If cells
are exposed only to initiating doses of carcinogen,
many preneoplastic changes occur but few are ex-
pressed.
Promoting agents probably act by causing a loss
of growth control in both initiated and non-initiated
cells. Promoters also cause a loss of cellular commit-
ment to terminal differentiation (20, 21). The loss of
growth control and altered cell differentiation may
or may not be independent events. The fact that
TPA-induced cell lines which have altered growth
control can differentiate normally when placed back
in vivo (11) suggests that the two pathways are in-
dependent. The important fact may be that in non-
initiated cells in vivo the effects of promoter expo-
sure are transient, while in initiated cells the effects
are permanent and heritable. Since many of the ex-
Table 5. Number of tracheal epithelial cells
at days 18 and 30 following
single and multiple MNNG exposures.
No. of
MNNG No. of cells (± S.D.) x 105
exposuresa At day 18b At day 30C
0 0.04 ± 0.03 0.02 ± 0.02
1 0.61 ± 0.51 4.59 ± 4.74
2 2.21 ± 0.91 9.76 ± 4.69
4 5.29 ± 3.44 18.23 ± 6.78
6 6.42 ± 3.69 18.01 ± 17.97
8 4.84 ± 1.69 22.36 ± 12.23
aCells were exposed to 0.1 ,Ag MNNG/mL for 3 hr in serum-
free medium on days 1, 3, 5, 7, 10, 12, 14, and 17 (one exposure
on day 1, 2 exposures on days 1 and 3, etc.).
bCell numbers were indirectly determined by estimating cell
density times X area covered by the cells.
cCell number was determined directly by dissociation of the
cultures and counting the cells using a hemacytometer.
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ogenous growth-controlling factors in whole animals
are not present under culture conditions, cells
exposed to TPA in cultural lose growth control and
never regain it until they are placed back in vivo.
Tracheal primary cultures appear to be a very
useful for quantitative studies of the effects of TPA
on initiated and non-initiated cells. If initiated cells
are more susceptible to growth alteration than non-
initiated cells, then initiated cells should preferen-
tially grow under conditions where noninitiated
cells would not. Since alterations in growth can be
detected as early as 30 days, the primary culture
system may be a rapid, useful tool to assay for sus-
pected tumor promoting agents.
Several other studies also suggest that promotion
is an important mechanism in respiratory carcino-
genesis. Using the heterotopic tracheal transplant
system, asbestos and nickel subsulfide were shown
to enhance the tumor response in DMBA-initiated
tracheal transplants (8). Additionally, alveologenic
tumors in mice can be promoted by systemic ad-
ministration of phorbol or butylated hydroxytoluene
as presented by Witschi elsewhere in this volume.
The mechanisms by which TPA can alter the fre-
quency of tumor induction and accelerate tumor for-
mation are unknown. The tracheal transplant and
cell culture systems described here provide a means
to study tumor promotion and identify substances
which have a potential to promote respiratory can-
cer.
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